Literature DB >> 18329849

Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.

Jing Sun1, Jing Nie, Bingtao Hao, Lu Li, Guichun Xing, Zhaoqing Wang, Ying Zhou, Qihong Sun, Guiyuan Li, Lingqiang Zhang, Fuchu He.   

Abstract

The centrosome associated protein Ceap-16 (also termed BLOS2) can accelerate the proliferation of mouse fibroblast NIH3T3 cells, which mechanism remains unclear. Here we identified tumor suppressor candidate BRD7 (bromodomain containing protein 7), which could negatively regulate cell proliferation and growth, as a novel Ceap-16-interacting protein. Ceap-16 and BRD7 interacted with each other both in vitro and in vivo. The C-terminus of BRD7 and the central region of Ceap-16 mediated the interaction. Through this binding, Ceap-16 could translocate from cytoplasm to the nucleus where it selectively inhibited the transcriptional suppression activity of BRD7 towards certain target genes including E2F3 and cyclin A. Moreover, Ceap-16, BRD7 and histone H3/H4 could form a complex and Ceap-16 did not compete with BRD7 binding to histones. These findings suggest a novel function for Ceap-16 in the transcriptional regulation through associating with BRD7.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329849     DOI: 10.1016/j.cellsig.2008.02.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  N-terminal truncated carboxypeptidase E expression is associated with poor prognosis of lung adenocarcinoma.

Authors:  Jing Sun; Dawei Meng; Li Li; Xin Tian; Yunji Jia; Hongyue Wang; Huihui Yu; Tiemin Sun; Aibing Qu; Hui Shen; Jimin Bao; Guirong Zhang
Journal:  Oncol Lett       Date:  2016-10-18       Impact factor: 2.967

2.  A data-mining approach to rank candidate protein-binding partners-The case of biogenesis of lysosome-related organelles complex-1 (BLOC-1).

Authors:  I A Rodriguez-Fernandez; E C Dell'Angelica
Journal:  J Inherit Metab Dis       Date:  2008-12-12       Impact factor: 4.982

3.  SLX2 interacting with BLOS2 is differentially expressed during mouse oocyte meiotic maturation.

Authors:  Xin-Jie Zhuang; Yu-Qiang Shi; Bo Xu; Lei Chen; Wen-Hao Tang; Jin Huang; Ying Lian; Ping Liu; Jie Qiao
Journal:  Cell Cycle       Date:  2014-05-28       Impact factor: 4.534

4.  Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.

Authors:  Sookil Tae; Vrajesh Karkhanis; Kevin Velasco; Mariana Yaneva; Hediye Erdjument-Bromage; Paul Tempst; Saïd Sif
Journal:  Nucleic Acids Res       Date:  2011-03-29       Impact factor: 16.971

5.  miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.

Authors:  Y Liu; R Zhao; H Wang; Y Luo; X Wang; W Niu; Y Zhou; Q Wen; S Fan; X Li; W Xiong; J Ma; X Li; M Tan; G Li; M Zhou
Journal:  Cell Death Dis       Date:  2016-03-24       Impact factor: 8.469

6.  BLOS2 negatively regulates Notch signaling during neural and hematopoietic stem and progenitor cell development.

Authors:  Wenwen Zhou; Qiuping He; Chunxia Zhang; Xin He; Zongbin Cui; Feng Liu; Wei Li
Journal:  Elife       Date:  2016-10-10       Impact factor: 8.140

7.  A genomic screen for angiosuppressor genes in the tumor endothelium identifies a multifaceted angiostatic role for bromodomain containing 7 (BRD7).

Authors:  Judy R van Beijnum; Patrycja Nowak-Sliwinska; Maaike van Berkel; Tse J Wong; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2017-09-26       Impact factor: 9.596

8.  Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.

Authors:  Minghua Wu; Xiayu Li; Xiaoling Li; Guiyuan Li
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

9.  Cooperative evolution of two different TEs results in lineage-specific novel transcripts in the BLOC1S2 gene.

Authors:  Hyeon-Mu Cho; Sang-Je Park; Se-Hee Choe; Ja-Rang Lee; Sun-Uk Kim; Yeung-Bae Jin; Ji-Su Kim; Sang-Rae Lee; Young-Hyun Kim; Jae-Won Huh
Journal:  BMC Evol Biol       Date:  2019-10-30       Impact factor: 3.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.